Green Lifescience Co., Ltd. (KOSDAQ:114450)

Green Lifescience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7,380	9,068	6,348	2,814	3,388	2,402
Short-Term Investments	259.28	127.56	5,669	2,300	7,800	7,800
Trading Asset Securities	4,077	3,690	2,436	11,835	5,015	4,930
Cash & Short-Term Investments	11,716	12,885	14,453	16,949	16,203	15,133
Cash Growth	-7.99%	-10.85%	-14.73%	4.60%	7.08%	-26.21%
Accounts Receivable	4,912	4,997	1,451	2,509	3,450	1,753
Other Receivables	77.51	38.99	8.54	333.75	114.13	284.56
Receivables	4,990	5,036	1,460	2,843	3,564	2,037
Inventory	6,010	3,905	5,311	6,014	5,732	6,649
Prepaid Expenses	186.65	52.01	160.15	42.62	735.77	438.83
Other Current Assets	71.28	112.3	328.73	595.04	657.55	314.22
Total Current Assets	22,974	21,991	21,712	26,443	26,892	24,572
Property, Plant & Equipment	13,556	13,533	13,256	27,112	36,846	35,626
Long-Term Investments	-	-	-	-	7,381	9,912
Other Intangible Assets	145.72	97.47	2.81	87.92	181.72	370.26
Long-Term Deferred Tax Assets	-	-	-	-	619.37	355.14
Long-Term Deferred Charges	62.3	11.92	24.91	-	-	-
Other Long-Term Assets	9,344	9,339	8,833	8,788	57.44	12.08
Total Assets	46,082	44,972	43,828	62,432	71,977	70,846
Accounts Payable	1,795	-	-	-	4,114	2,835
Accrued Expenses	138.92	-	-	-	2.12	136.07
Short-Term Debt	7,300	4,800	4,800	6,488	7,433	6,211
Current Portion of Leases	79.44	41.01	104.04	117.85	104.86	170.18
Current Unearned Revenue	21.9	46.72	34	34	-	-
Other Current Liabilities	1,125	3,426	2,455	2,796	3,588	1,429
Total Current Liabilities	10,460	8,314	7,394	9,437	15,242	10,781
Long-Term Leases	495.69	530.9	28.82	18.27	57.76	31.42
Other Long-Term Liabilities	29.1	21.61	8.12	6.78	8.19	6.67
Total Liabilities	11,444	9,224	7,874	9,793	15,679	11,475
Common Stock	10,000	10,000	10,000	7,500	7,500	7,500
Additional Paid-In Capital	15,025	15,025	36,425	38,956	38,956	38,956
Retained Earnings	11,636	12,746	-10,105	6,232	9,680	12,820
Treasury Stock	-2,023	-2,023	-366.29	-	-	-
Comprehensive Income & Other	-0	-0	0	-48.7	162.39	95.97
Shareholders' Equity	34,638	35,748	35,954	52,639	56,298	59,371
Total Liabilities & Equity	46,082	44,972	43,828	62,432	71,977	70,846
Total Debt	7,875	5,372	4,933	6,624	7,595	6,413
Net Cash (Debt)	3,841	7,513	9,520	10,324	8,608	8,720
Net Cash Growth	-50.90%	-21.08%	-7.79%	19.93%	-1.28%	-42.80%
Net Cash Per Share	201.25	390.48	476.93	516.22	430.42	436.01
Filing Date Shares Outstanding	19.09	19.09	19.83	20	20	20
Total Common Shares Outstanding	19.09	19.09	19.83	20	20	20
Working Capital	12,514	13,677	14,319	17,007	11,651	13,791
Book Value Per Share	1814.70	1872.83	1812.66	2631.95	2814.92	2968.56
Tangible Book Value	34,492	35,650	35,951	52,551	56,117	59,001
Tangible Book Value Per Share	1807.07	1867.72	1812.52	2627.55	2805.83	2950.04
Land	8,450	8,450	8,425	8,329	7,923	7,923
Buildings	7,918	7,918	7,846	16,077	13,381	13,381
Machinery	35,900	35,677	35,434	38,766	39,913	37,596
Construction In Progress	84.9	-	23.1	207.03	11,769	10,758

Source: S&P Global Market Intelligence. Standard template. Financial Sources.